SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis

Affiliations

• ¹ Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
• ² Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC, Australia.
• ³ Infrared Microspectroscopy Beamline, ANSTO - Australian Synchrotron, Clayton, VIC, Australia.
• ⁴ Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia. sam.el-osta@monash.edu.
• ⁵ Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Hong Kong SAR; Hong Kong Institute of Diabetes and Obesity, CUHK, Hong Kong SAR; Prince of Wales Hospital, Li Ka Shing Institute of Health Sciences, CUHK, Shatin, Hong Kong, China. sam.el-osta@monash.edu.
• ⁶ University College Copenhagen, Faculty of Health, Department of Technology, Biomedical Laboratory Science, Copenhagen, Denmark. sam.el-osta@monash.edu.